TW201618746A - Exothermic composition for oral use and toothpaste composition - Google Patents
Exothermic composition for oral use and toothpaste composition Download PDFInfo
- Publication number
- TW201618746A TW201618746A TW104134756A TW104134756A TW201618746A TW 201618746 A TW201618746 A TW 201618746A TW 104134756 A TW104134756 A TW 104134756A TW 104134756 A TW104134756 A TW 104134756A TW 201618746 A TW201618746 A TW 201618746A
- Authority
- TW
- Taiwan
- Prior art keywords
- mass
- toothpaste
- composition
- heat
- oral
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 239000000606 toothpaste Substances 0.000 title claims description 24
- 229940034610 toothpaste Drugs 0.000 title claims description 24
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 28
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000010457 zeolite Substances 0.000 claims abstract description 28
- 239000011230 binding agent Substances 0.000 claims abstract description 17
- 229920005862 polyol Polymers 0.000 claims abstract description 13
- 150000003077 polyols Chemical class 0.000 claims abstract description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 9
- 229920001400 block copolymer Polymers 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 7
- 238000005191 phase separation Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229920001983 poloxamer Polymers 0.000 description 6
- -1 polyoxypropylene Polymers 0.000 description 6
- 229920001451 polypropylene glycol Polymers 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 230000020169 heat generation Effects 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 229960001631 carbomer Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229960000502 poloxamer Drugs 0.000 description 4
- 229920001993 poloxamer 188 Polymers 0.000 description 4
- 229920001992 poloxamer 407 Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 239000004075 cariostatic agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 2
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 2
- 229940043234 carbomer-940 Drugs 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000002554 disease preventive effect Effects 0.000 description 2
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical group OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940044519 poloxamer 188 Drugs 0.000 description 2
- 229940044476 poloxamer 407 Drugs 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 235000019643 salty taste Nutrition 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- GSHUZVSNIBLGMR-UHFFFAOYSA-N calcium;1,1-dioxo-1,2-benzothiazol-3-one Chemical compound [Ca].C1=CC=C2C(=O)NS(=O)(=O)C2=C1 GSHUZVSNIBLGMR-UHFFFAOYSA-N 0.000 description 1
- 229940085237 carbomer-980 Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明涉及一種口腔用發熱組合物。The present invention relates to an oral heat generating composition.
本申請要求於2014年10月31日向韓國專利局提交的韓國專利申請第10-2014-0149863號的申請日的利益,其全部內容包含於本說明書中。The present application claims the benefit of the filing date of the Korean Patent Application No. 10-2014-0149863 filed on Jan. 31, 2014, the entire disclosure of which is incorporated herein.
作為去除牙齒表面的牙結石等異物的用途來使用的牙膏,其含有具代表性的作為防齲劑的氟,從而以預防齲齒為目的來使用。除了防齲劑外,通常在組成牙膏的成分中,將潤濕劑、黏合劑、藥效劑及研磨劑等作為主要成分來使用。The toothpaste which is used for the purpose of removing foreign matter such as calculus on the tooth surface contains fluorine which is a representative anti-caries agent, and is used for the purpose of preventing dental caries. In addition to the anti-caries agent, a wetting agent, a binder, a medicinal agent, an abrasive, and the like are usually used as a main component in the components constituting the toothpaste.
牙膏中,除了這種預防齲齒的目的以外,為了預防諸如牙齦炎或牙槽膿溢等的引起牙齦發炎,並破壞牙周組織的牙周疾病,會使用用於促進牙齦血液迴圈的添加劑。In the toothpaste, in addition to the purpose of preventing dental caries, in order to prevent inflammation of the gums such as gingivitis or alveolar pus, and to destroy periodontal disease of periodontal tissues, an additive for promoting blood circulation of the gums is used.
美國授權專利公報第4647451號中公開有一種使用無水沸石來製備具有發熱特性的牙膏的技術。當無水沸石在口腔內與唾液等水分接觸時,因沸石的水化反應而產生能夠感覺到溫熱感程度的熱,從而促進牙齦的血液迴圈。A technique for preparing a toothpaste having heat-generating characteristics using anhydrous zeolite is disclosed in U.S. Patent Application Publication No. 4,644,451. When the anhydrous zeolite is brought into contact with water such as saliva in the oral cavity, heat of a degree of warmth is generated by the hydration reaction of the zeolite, thereby promoting blood circulation of the gums.
然而,在美國授權專利公報第4647451號中,將脫乙醯化雜多糖S-60(deacetylated heteropolysaccharide S-60)作為黏合劑與無水沸石一起使用,但不能確保作為牙膏的穩定性。However, in U.S. Patent No. 4,474,451, deacetylated heteropolysaccharide S-60 is used as a binder together with anhydrous zeolite, but stability as a toothpaste cannot be ensured.
此外,對於現有的膏狀牙膏,為了防止研磨劑和液體成分的分離而維持製備材料的形態穩定性,從而給予適宜的黏性,以及為了調節泡沫而使用黏合劑,然而,對於膏狀牙膏,為了使製備材料具有適宜的濕氣和可塑性,且防止牙膏的乾燥固化而通常要求使用潤濕劑。Further, with the conventional paste toothpaste, in order to prevent separation of the abrasive and the liquid component, the morphological stability of the preparation material is maintained, thereby imparting appropriate viscosity, and using a binder for adjusting the foam, however, for the creamy toothpaste, A wetting agent is generally required in order to impart suitable moisture and plasticity to the preparation material and to prevent dry curing of the toothpaste.
因此,對於包含無水沸石的發熱牙膏的組合物來說,要求在包含潤濕劑的同時,也具有穩定性,以能夠維持黏度,並且不會發生固體和液體分離的脫水收縮(이액)現象。Therefore, for a composition of a heated toothpaste containing an anhydrous zeolite, it is required to have a wetting agent at the same time as stability, so as to maintain the viscosity, and a phenomenon of hydrating shrinkage of solid and liquid separation does not occur.
此外,已知有藉由水化時使用發熱特性優異的無水氯化鈣,從而在漱口時提供溫熱感的技術,但是,氯化鈣由於其特有的很強的苦味,因此在實際作為牙膏使用時存在問題。Further, there is known a technique in which an anhydrous calcium chloride having excellent heat generation characteristics is used in hydration to provide a warm feeling at the time of rinsing, but calcium chloride is actually used as a characteristic bitter taste. There is a problem with the use of toothpaste.
發明所欲解決之問題Problem to be solved by the invention
本發明人的目的在於,提供一種口腔用發熱組合物,口腔用發熱組合物含有無水沸石,因此在口腔內具有發熱特性,同時還含有潤濕劑,因此還能夠向製備材料提供適宜的濕氣和可塑性,同時在長時間保存的情況下,也能夠維持黏度,且固體和液體分離的脫水收縮現象也得到了改善。The present inventors have an object to provide an oral heat-generating composition which contains anhydrous zeolite and thus has heat-generating properties in the oral cavity and also contains a wetting agent, thereby providing suitable moisture to the preparation material. And plasticity, while maintaining the viscosity for a long time, the syneresis phenomenon of solid and liquid separation is also improved.
解決問題之技術手段Technical means of solving problems
為了實現上述目的,本發明提供一種包含無水沸石、多元醇及黏合劑的口腔用發熱組合物。In order to achieve the above object, the present invention provides an oral heat-generating composition comprising an anhydrous zeolite, a polyol, and a binder.
對照先前技術之功效Control the efficacy of prior art
根據本發明的口腔用發熱組合物含有無水沸石,因此在口腔內具有發熱特性,同時還含有潤濕劑,因此還能夠向製備材料提供適宜的濕氣和可塑性,同時在長時間保存的情況下,也能夠維持黏度,並且能夠使固體和液體分離的脫水收縮現象得到抑制。The oral heat-generating composition according to the present invention contains an anhydrous zeolite and thus has a heat-generating property in the oral cavity, and also contains a wetting agent, thereby also providing suitable moisture and plasticity to the preparation material while being stored for a long period of time. It is also capable of maintaining viscosity and suppressing the syneresis phenomenon in which solids and liquids are separated.
另外,根據本發明的口腔用發熱組合物由於含有無水沸石,因此即使作為無水劑型,漱口時也具有比較良好的口感,且發熱特性也優異。Further, since the oral heat-generating composition of the present invention contains anhydrous zeolite, even when it is an anhydrous dosage form, it has a relatively good mouthfeel at the time of mouthwashing, and is excellent in heat generation characteristics.
本發明提供一種包含無水沸石、多元醇及黏合劑的口腔用發熱組合物。The present invention provides an oral heat-generating composition comprising anhydrous zeolite, a polyol and a binder.
本發明的口腔用發熱組合物由於包含無水沸石,因此與水反應時會發熱,從而在使用牙膏時能夠感覺到溫熱感,並且與包含因特有的苦味和鹹味強而使用感不好的無水氯化鈣的情況不同,其苦味和鹹味不強,因此使用感優異。Since the oral heat-generating composition of the present invention contains anhydrous zeolite, it generates heat when it reacts with water, so that when a toothpaste is used, a warm feeling can be felt, and an anhydrous taste containing a characteristic bitterness and a salty taste is not good. In the case of calcium chloride, the bitterness and the salty taste are not strong, and therefore the feeling of use is excellent.
對於本發明的一實施方式,上述無水沸石只要是與水反應而發熱的無水沸石,則不受特別的限定,例如為沸石A、沸石X、沸石Y、沸石L等通式xM2/n O·Al2 O3 ·ySiO2 ·zH2 O(式中,x、y及z表示任意的數,M表示鹼金屬或鹼土金屬類金屬,n表示其原子價。)所示的沸石的酐。In one embodiment of the present invention, the anhydrous zeolite is not particularly limited as long as it is an anhydrous zeolite which generates heat by reaction with water, and is, for example, a general formula xM 2/n O such as zeolite A, zeolite X, zeolite Y or zeolite L. - Al 2 O 3 ·ySiO 2 ·zH 2 O (wherein x, y and z represent an arbitrary number, M represents an alkali metal or an alkaline earth metal, and n represents the valence of the valence.) The anhydride of the zeolite.
對於本發明的一實施方式,上述多元醇為選自甘油、丙二醇、丁二醇、二丙二醇及聚乙二醇中的任一種或兩種以上。多元醇在無水狀態時,能夠在進行水化的同時發熱,尤其是聚乙二醇的這種發熱能力最優異,因此優選。In one embodiment of the present invention, the polyol is one or more selected from the group consisting of glycerin, propylene glycol, butylene glycol, dipropylene glycol, and polyethylene glycol. When the polyol is in a water-free state, it can be heated while being hydrated, and in particular, polyethylene glycol has the most excellent heat generation ability, which is preferable.
對於本發明的一實施方式,上述黏合劑為選自聚乙烯吡咯烷酮、丙烯酸酯類聚合物及聚氧乙烯-聚氧丙烯-聚氧乙烯嵌段共聚物中的任一種或兩種以上。In one embodiment of the present invention, the binder is one or more selected from the group consisting of polyvinylpyrrolidone, an acrylate polymer, and a polyoxyethylene-polyoxypropylene-polyoxyethylene block copolymer.
對於現有的牙膏,由於混合有大量的水,因此,將水溶性高分子作為黏合劑來使用,但是對於本發明中含有的沸石,為了維持發熱特性,沸石應為無水劑型,因此在使用僅在水溶液中起作用的水溶性高分子時,不能得到所希望的效果,與此相反,聚乙烯吡咯烷酮、丙烯酸酯類聚合物及聚氧乙烯-聚氧丙烯-聚氧乙烯嵌段共聚物及它們的組合在無水劑型中作為黏合劑使用時,其效果也優異。In the conventional toothpaste, since a large amount of water is mixed, the water-soluble polymer is used as a binder. However, in order to maintain the heat generation characteristics of the zeolite contained in the present invention, the zeolite should be an anhydrous dosage form, and therefore In contrast, when a water-soluble polymer acts in an aqueous solution, a desired effect cannot be obtained. In contrast, polyvinylpyrrolidone, an acrylate polymer, and a polyoxyethylene-polyoxypropylene-polyoxyethylene block copolymer and their When used in combination as an adhesive in an anhydrous dosage form, the effect is also excellent.
上述丙烯酸酯類聚合物,具體地可以為聚丙烯酸酯或丙烯酸鈉,更具體地,可以為由路博潤公司(Lubrizol corporation)製備的商品名為卡波姆980或商品名為卡波姆940的產品。The above acrylate-based polymer may specifically be polyacrylate or sodium acrylate, and more specifically, may be manufactured by Lubrizol Corporation under the trade name carbomer 980 or under the trade name carbomer 940. The product.
上述聚氧乙烯-聚氧丙烯-聚氧乙烯(PEG-PPG-PEG)嵌段共聚物,其聚氧丙烯(PPG)嵌段的分子量(polyoxypropylene molecular mass)為4,000g/mol,以整體聚氧乙烯-聚氧丙烯-聚氧乙烯嵌段共聚物質量計,聚氧乙烯可以為70質量%,具體地,可以為泊洛沙姆407(Poloxamer 407),更具體地,可以為由巴斯夫(BASF)公司製備的商品名為普朗尼克F127(Pluronic F127)或由禾大(Croda)公司製備的商品名為Synperonic PE/F 127的產品。The above polyoxyethylene-polyoxypropylene-polyoxyethylene (PEG-PPG-PEG) block copolymer, the polyoxypropylene molecular mass of the polyoxypropylene (PPG) block is 4,000 g/mol, and the overall polyoxygenation The ethylene-polyoxypropylene-polyoxyethylene block copolymer mass meter, the polyoxyethylene may be 70% by mass, specifically, may be poloxamer 407 (Poloxamer 407), and more specifically, may be BASF (BASF) The company's trade name is Pluronic F127 or the product sold under the trade name Synperonic PE/F 127 by Croda.
上述聚氧乙烯-聚氧丙烯-聚氧乙烯(PEG-PPG-PEG)嵌段共聚物,其聚氧丙烯(PPG)嵌段的分子量(polyoxypropylene molecular mass)為4,000g/mol,以整體聚氧乙烯-聚氧丙烯-聚氧乙烯嵌段共聚物質量計,聚氧乙烯可以為80質量%,具體地,可以為泊洛沙姆188(Poloxamer 188),更具體地,可以為由巴斯夫(BASF)公司製備的商品名為普朗尼克F68(Pluronic F68)或由禾大公司製備的商品名為Synperonic PE/F68的產品。The above polyoxyethylene-polyoxypropylene-polyoxyethylene (PEG-PPG-PEG) block copolymer, the polyoxypropylene molecular mass of the polyoxypropylene (PPG) block is 4,000 g/mol, and the overall polyoxygenation The ethylene-polyoxypropylene-polyoxyethylene block copolymer mass meter, the polyoxyethylene may be 80% by mass, specifically, may be poloxamer 188 (Poloxamer 188), and more specifically, may be BASF (BASF) The company's trade name is Pluronic F68 (Pluronic F68) or a product made by Heda Company under the trade name Synperonic PE/F68.
對於本發明的一實施方式,以整體組合物質量計,無水沸石的含量為5質量%以上且50質量%以下。如果無水沸石的含量為5質量%以下,則漱口時幾乎感覺不到發熱的效果,如果為50質量%以上,則因過多的發熱而存在漱口時感覺到疼痛的問題。In one embodiment of the present invention, the content of the anhydrous zeolite is 5% by mass or more and 50% by mass or less based on the total mass of the composition. When the content of the anhydrous zeolite is 5% by mass or less, the effect of heat generation is hardly felt at the time of rinsing, and if it is 50% by mass or more, there is a problem that pain is felt when there is excessive sputum.
對於本發明的一實施方式,以整體組合物質量計,多元醇的含量為30質量%以上且80質量%以下。如果多元醇的含量為30質量%以下,則因過多的粉體量而使劑型變得過於堅硬,如果為80質量%以上,則因過多的多元醇含量而存在劑型內可混合的粉體量變得非常少的劑型上的問題。In one embodiment of the present invention, the content of the polyol is 30% by mass or more and 80% by mass or less based on the total mass of the composition. When the content of the polyol is 30% by mass or less, the dosage form becomes too hard due to an excessive amount of the powder, and if it is 80% by mass or more, the amount of the powder which can be mixed in the dosage form due to the excessive polyol content is changed. Very little problem with the dosage form.
對於本發明的一實施方式,以整體組合物質量計,黏合劑的含量為0.1質量%以上且5質量%以下。如果黏合劑的含量為0.1質量%以下,則長期保管時不能抑制相分離現象,如果為5質量%以上,則因過度的黏性,從而在製備中難以混合,並且將該組合物填充到容器中時也存在問題。In one embodiment of the present invention, the content of the binder is 0.1% by mass or more and 5% by mass or less based on the total mass of the composition. When the content of the binder is 0.1% by mass or less, the phase separation phenomenon cannot be suppressed during long-term storage, and if it is 5% by mass or more, excessive adhesion is caused, and it is difficult to mix in preparation, and the composition is filled into a container. There are also problems in the middle.
對於本發明的一實施方式,上述口腔用發熱組合物進一步包含選自防齲劑、牙周疾病預防劑、牙齒冷酸緩解劑、牙齒美白劑、研磨劑、發泡劑、賦香劑、甜味劑及保存劑中的任一種或兩種以上。In one embodiment of the present invention, the oral heat-generating composition further comprises a selected from the group consisting of an expectorant, a periodontal disease preventive agent, a tooth cold acid reliever, a tooth whitening agent, an abrasive, a foaming agent, a flavoring agent, and a sweetener. Any one or two or more of a taste agent and a preservative.
上述防齲劑可以為選自單氟磷酸鈉、氟化鈉及氟化錫中的任一種或兩種以上。The anti-caries agent may be any one or more selected from the group consisting of sodium monofluorophosphate, sodium fluoride, and tin fluoride.
上述牙周疾病預防劑可以為選自尿囊素、甘草酸二鉀(dipotassium glycyrrhizinate)、ε-氨基己酸、氨甲環酸、日扁柏素(hinokitiol)、溶解酵素、維生素E、維生素E的衍生物及氯化鈉中的任一種或兩種以上。The periodontal disease preventive agent may be selected from the group consisting of allantoin, dipotassium glycyrrhizinate, ε-aminocaproic acid, tranexamic acid, hinokitiol, lysozyme, vitamin E, and vitamin E. Any one or two or more of a derivative and sodium chloride.
上述牙齒冷酸緩解劑可以為選自硝酸鉀、磷酸三鈣及氯化鍶中的任一種或兩種以上。The dental cold acid relieving agent may be any one or more selected from the group consisting of potassium nitrate, tricalcium phosphate, and barium chloride.
上述研磨劑可以為選自重質碳酸鈣、沉澱碳酸鈣及二氧化矽中的任一種或兩種以上。The polishing agent may be any one or more selected from the group consisting of heavy calcium carbonate, precipitated calcium carbonate, and cerium oxide.
上述發泡劑可以為月桂基硫酸鈉。The above blowing agent may be sodium lauryl sulfate.
上述賦香劑可以為薄荷腦和/或薄荷油。The above scenting agent may be menthol and/or peppermint oil.
上述甜味劑可以為選自糖精、甜菊苷及木糖醇中的任一種或兩種以上。上述糖精可以為糖精鈉或糖精鈣。The sweetener may be any one or more selected from the group consisting of saccharin, stevioside, and xylitol. The above saccharin may be sodium saccharin or calcium saccharin.
上述保存劑可以為對羥基苯甲酸甲酯和/或苯甲酸丁酯。The above preservative may be methyl p-hydroxybenzoate and/or butyl benzoate.
上述牙齒美白劑可以為選自過氧化氫、過氧化脲及過氧化鈣中的任一種或兩種以上。The tooth whitening agent may be any one or more selected from the group consisting of hydrogen peroxide, urea peroxide, and calcium peroxide.
本發明提供一種包含前述的口腔用發熱組合物的牙膏。The present invention provides a toothpaste comprising the aforementioned oral heat-generating composition.
對於本發明的一實施方式,牙膏可以為牙粉、液狀牙膏(액상 치약)及液體牙膏。For an embodiment of the present invention, the toothpaste may be a tooth powder, a liquid toothpaste, and a liquid toothpaste.
以下,將藉由試驗例及劑型例更加具體地說明本發明的結構及效果。但這些試驗例及劑型例僅是為了加強對本發明的理解而作為例示的目的而提供的,本發明的範疇及範圍並不限定於下述例。Hereinafter, the structure and effects of the present invention will be more specifically described by way of test examples and dosage forms. However, these test examples and the formulation examples are provided for the purpose of exemplifying the understanding of the present invention, and the scope and scope of the present invention are not limited to the following examples.
[製備例1]多元醇和黏合劑的相容性確認[Preparation Example 1] Confirmation of Compatibility of Polyol and Binder
實施例1至3及比較例1至6的牙膏組合物藉由下述表一的組成來製備。將香料、糖精鈉、單氟磷酸鈉及黏合劑(卡波姆、聚乙烯吡咯烷酮、泊洛沙姆及纖維素膠等)溶解或分散於作為多元醇的聚乙二醇和甘油中。然後,在真空狀態下加入碳酸鈣、含水矽酸、無水沸石或氯化鈣等的無機粉體和月桂基硫酸鈉,並進行混合,從而製備牙膏組合物。The toothpaste compositions of Examples 1 to 3 and Comparative Examples 1 to 6 were prepared by the compositions of Table 1 below. The perfume, sodium saccharin, sodium monofluorophosphate, and a binder (carbomer, polyvinylpyrrolidone, poloxamer, cellulose gum, etc.) are dissolved or dispersed in polyethylene glycol and glycerin as polyols. Then, an inorganic powder such as calcium carbonate, aqueous citric acid, anhydrous zeolite or calcium chloride, and sodium lauryl sulfate are added under vacuum and mixed to prepare a toothpaste composition.
作為卡波姆,使用了由路博潤公司製備的商品名為卡波姆940的產品,作為聚乙烯吡咯烷酮,使用了由巴斯夫公司製備的商品名為LUVISCOL K30的產品,作為泊洛沙姆,使用了巴斯夫公司製備的商品名為Lutrol F127的產品。As carbomer, a product manufactured by Lubrizol Corporation under the trade name Carbomer 940 is used, and as polyvinylpyrrolidone, a product manufactured by BASF Corporation under the trade name LUVISCOL K30 is used as a poloxamer. A product manufactured by BASF Corporation under the trade name Lutrol F127 was used.
表一
*單位:對組合物整體的質量%*Unit: % of the total mass of the composition
[試驗例1]劑型穩定性[Test Example 1] Formulation stability
(1)黏度變化(1) Viscosity change
將實施例及比較例中製得的約100g的牙膏組合物加入到100ml的燒杯中,並用布魯克菲爾德黏度計,以0.5rpm的主軸轉速D測定1分鐘,從而得到下述表二的結果。About 100 g of the toothpaste composition prepared in the examples and the comparative examples was placed in a 100 ml beaker, and measured by a Brookfield viscometer at a spindle speed D of 0.5 rpm for 1 minute, thereby obtaining the results of the following Table 2.
表二
*單位:cps*Unit: cps
觀察表二,可以確認與分別將卡波姆、聚乙烯吡咯烷酮及泊洛沙姆作為黏合劑來使用的初始黏度為80,000cps以上,次日之後的黏度為104,000cps以上的實施例1至3不同,將其它成分作為黏合劑來使用的比較例1至6的情況下,該黏合劑對黏度的形成幾乎沒有貢獻。Looking at Table 2, it can be confirmed that the initial viscosity of carbomer, polyvinylpyrrolidone, and poloxamer as a binder is 80,000 cps or more, and the viscosity of 104,000 cps or more after the next day is different. In the case of Comparative Examples 1 to 6 in which other components were used as a binder, the binder hardly contributed to the formation of viscosity.
(2)相分離(2) Phase separation
將製備例1中製得的牙膏組合物,在室溫、45℃烘箱及迴圈烘箱(以-10~45℃溫度範圍變化)中保存,並經過一個月後評價相分離現象,其結果如下。The toothpaste composition prepared in Preparation Example 1 was stored in an oven at 45 ° C and a loop oven (varied in a temperature range of -10 to 45 ° C), and the phase separation phenomenon was evaluated after one month. The results are as follows: .
<評價基準><Evaluation criteria>
良好:完全沒有相分離Good: no phase separation at all
普通:發生相分離現象非常微弱Ordinary: phase separation is very weak
不良:相分離嚴重Bad: serious phase separation
表三
觀察表三,對相分離現象進行評價的結果,可以確認使用聚乙烯吡咯烷酮的實施例2的劑型穩定性最優異,並且使用卡波姆的實施例1及使用泊洛沙姆的實施例也可以使用。然而,可以知道除此之外的黏合劑中均發生了分離現象,從而難以使用。Observation of Table 3, the results of evaluation of the phase separation phenomenon, it was confirmed that the formulation of Example 2 using polyvinylpyrrolidone was the most excellent in stability, and Example 1 using carbomer and the example using poloxamer were also possible. use. However, it can be known that separation occurs in the binder other than this, and it is difficult to use.
[製備例2]使用性確認[Preparation Example 2] usability confirmation
實施例2、4及比較例7及8的牙膏組合物藉由下述表四的組成來製備。The toothpaste compositions of Examples 2, 4 and Comparative Examples 7 and 8 were prepared by the compositions of Table 4 below.
表四
*單位:對組合物整體的質量%*Unit: % of the total mass of the composition
[試驗例2]使用感評價[Test Example 2] Evaluation of use feeling
本試驗中,為了調查各實施例和比較例中製得的牙膏的使用感,從而進行使用感評價。In this test, in order to investigate the feeling of use of the toothpaste prepared in each of the examples and the comparative examples, the feeling of use was evaluated.
將40名20歲至50歲年齡段的男女消費者作為對象,讓他們使用1週後進行問卷調查,將其結果示於表五中。Forty male and female consumers between the ages of 20 and 50 were asked to use a questionnaire survey one week later, and the results are shown in Table 5.
<評價基準><Evaluation criteria>
溫熱感:非常強5,強4,普通3,幾乎沒有2,沒有1Warm feeling: very strong 5, strong 4, normal 3, almost no 2, no 1
苦味:非常強5,強4,普通3,幾乎沒有2,沒有1Bitterness: very strong 5, strong 4, normal 3, almost no 2, no 1
刺激:非常強5,強4,普通3,幾乎沒有2,沒有1Stimulation: very strong 5, strong 4, normal 3, almost no 2, no 1
滿意度:非常好5,好4,普通3,不好2,非常不好1Satisfaction: very good 5, good 4, normal 3, not good 2, very bad 1
表5
對於使用氯化鈣的比較例7及8,由於非常強的苦味和刺激感,因此即使在比較高的溫熱感下,其滿意度也非常低。相反,可以知道對於含有50質量%的無水沸石的實施例4,雖然能夠感覺到強的溫熱感,但是根據其的刺激也隨之上升,並且可以知道含有10%質量%無水沸石的實施例2的全面性滿意度優異。In Comparative Examples 7 and 8 using calcium chloride, since the bitterness and irritation were very strong, the satisfaction was extremely low even under a relatively high warm feeling. On the other hand, in Example 4 containing 50% by mass of anhydrous zeolite, although a strong warm feeling can be felt, the stimulation according thereto is also increased, and an example containing 10% by mass of anhydrous zeolite can be known. 2 Overall satisfaction is excellent.
無no
無no
無no
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2014-0149863 | 2014-10-31 | ||
KR1020140149863A KR102199880B1 (en) | 2014-10-31 | 2014-10-31 | Exothermic composition for oral use |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201618746A true TW201618746A (en) | 2016-06-01 |
TWI687234B TWI687234B (en) | 2020-03-11 |
Family
ID=55857801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104134756A TWI687234B (en) | 2014-10-31 | 2015-10-23 | Exothermic composition for oral use and toothpaste composition |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR102199880B1 (en) |
TW (1) | TWI687234B (en) |
WO (1) | WO2016068532A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113398011A (en) * | 2021-07-16 | 2021-09-17 | 邓家能 | Thermal inductance toothpaste and preparation method thereof |
CN114099524A (en) * | 2021-11-30 | 2022-03-01 | 上海格芒商贸有限责任公司 | Oral spray with effect of relieving piquancy |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132771A (en) * | 1977-08-24 | 1979-01-02 | Schreiber Ronald S | Warm two tone flavored dentifrice |
US4647451A (en) * | 1984-05-11 | 1987-03-03 | Colgate-Palmolive Company | Anhydrous dentifrice |
JPH11335252A (en) * | 1998-05-26 | 1999-12-07 | Kao Corp | Dentifrice composition |
US6306371B1 (en) * | 2000-02-18 | 2001-10-23 | Colgate-Palmolive Company | Color stable silver zeolite containing dentifrice compositions |
US20030003059A1 (en) * | 2001-04-03 | 2003-01-02 | Frederic Dana | Dentifrice compositions |
KR20050114537A (en) * | 2004-06-01 | 2005-12-06 | 주식회사 엘지생활건강 | Toothpaste composition containing the alkyl silane-treated calcium carbonate and dibaic calcium phosphate as an abrasive |
US20060045860A1 (en) * | 2004-08-26 | 2006-03-02 | Bioderm Research | Zinc Zeolite Based Deodorants and Deodorizers |
JP4647451B2 (en) | 2005-09-28 | 2011-03-09 | 株式会社野村総合研究所 | Map integration apparatus and method |
KR101331734B1 (en) * | 2005-12-15 | 2013-11-20 | 라이온 가부시키가이샤 | Toothpaste composition |
US10806685B2 (en) * | 2011-09-30 | 2020-10-20 | Rubicon Research Private Limited | Oral care compositions |
-
2014
- 2014-10-31 KR KR1020140149863A patent/KR102199880B1/en active Active
-
2015
- 2015-10-16 WO PCT/KR2015/010953 patent/WO2016068532A1/en active Application Filing
- 2015-10-23 TW TW104134756A patent/TWI687234B/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113398011A (en) * | 2021-07-16 | 2021-09-17 | 邓家能 | Thermal inductance toothpaste and preparation method thereof |
CN114099524A (en) * | 2021-11-30 | 2022-03-01 | 上海格芒商贸有限责任公司 | Oral spray with effect of relieving piquancy |
CN114099524B (en) * | 2021-11-30 | 2023-06-23 | 上海芒歌科技有限公司 | Oral spray with peppery relieving effect |
Also Published As
Publication number | Publication date |
---|---|
KR20160050814A (en) | 2016-05-11 |
KR102199880B1 (en) | 2021-01-08 |
TWI687234B (en) | 2020-03-11 |
WO2016068532A1 (en) | 2016-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5816549B2 (en) | Compositions and methods for improving fluoride uptake using bioactive glass | |
TWI440473B (en) | Low water fluoride stannous and zinc citrate dentifrice with improved stability, rheology and potency | |
TWI556834B (en) | Surfactant systems for zinc containing compositions | |
US9877911B2 (en) | Non-aqueous oral care compositions | |
TWI432216B (en) | Dentifrice composition | |
JP6524072B2 (en) | Oral composition | |
KR20150092749A (en) | Peroxide-stable oral care compositions | |
TWI552767B (en) | Oral care compositions | |
EP3166692B1 (en) | Oral care formulation system providing amorphous calcium phosphate | |
JP2016503018A (en) | Flowable peroxide-containing oral care composition | |
JP2013163656A (en) | Dentifrice | |
JP5527219B2 (en) | Toothpaste composition | |
US20210378923A1 (en) | Novel composition | |
CN102772332A (en) | Hetian jade nano-powder, ultra-fine powder, powder toothpaste and production process of powder toothpaste | |
JP7152402B2 (en) | anhydrous dentifrice | |
TW201618746A (en) | Exothermic composition for oral use and toothpaste composition | |
TWI568450B (en) | Oral care whitening compositions | |
JP5627190B2 (en) | Dentifrice composition | |
Kaur et al. | Neoteric Non-Fluoride Enamel Remineralization Systems: A Review | |
JP2020521792A (en) | Pump type dentifrice composition | |
JP5845867B2 (en) | Dentifrice composition | |
CN108883050A (en) | ι carragheen-polyvalent cation alginates adhesive composition | |
JP2018076273A (en) | Liquid oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |